Table 3.
Items | Hazard ratio (95% CI) | P |
---|---|---|
CV death | ||
Diabetes | 2.61 (1.27–5.61) | 0.029 |
Male | 0.74 (0.26–2.14) | 0.580 |
Age | 1.02 (0.98–1.06) | 0.361 |
LVEF | 0.94 (0.93–0.99) | 0.017 |
Lesion length | 0.98 (0.93–1.04) | 0.502 |
Multivessel disease | 0.93 (0.41–2.07) | 0.654 |
Renal dysfunction | 1.13 (0.72–3.06) | 0.653 |
Reference vessel diameter | 0.69 (0.48–1.27) | 0.328 |
DES versus BMS | 0.51 (0.30–0.86) | 0.045 |
IPTW adjusted | ||
DES versus BMS | 0.41 (0.21–0.63) | 0.029 |
MI | ||
Diabetes | 2.86 (1.08–7.56) | 0.031 |
Male | 1.86 (0.65–5.38) | 0.259 |
Age | 1.00 (0.92–1.08) | 0.918 |
LVEF | 0.96 (0.92–0.99) | 0.033 |
Lesion length | 0.96 (0.87–1.05) | 0.367 |
Multivessel disease | 0.92 (0.34–2.49) | 0.864 |
Renal dysfunction | 0.62 (0.19–2.70) | 0.716 |
Reference vessel diameter | 0.33 (0.12–0.88) | 0.035 |
DES versus BMS | 0.31 (0.09–1.03) | 0.065 |
IPTW adjusted | ||
DES versus BMS | 0.29 (0.08–0.92) | 0.037 |
CV: Cardiovascular; LVEF: Left ventricular ejection fraction; DES: Drug-eluting stent; BMS: Bare-metal stent; IPTW: Inverse-probability-of-treatment weighting; MI: Myocardial infarction; CI: Confidence interval.